...
首页> 外文期刊>Pediatric critical care medicine: a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies >Whole blood assessment of neutrophil gelatinase-associated lipocalin versus pediatricRIFLE for acute kidney injury diagnosis and prognosis after pediatric cardiac surgery: Cross-sectional study
【24h】

Whole blood assessment of neutrophil gelatinase-associated lipocalin versus pediatricRIFLE for acute kidney injury diagnosis and prognosis after pediatric cardiac surgery: Cross-sectional study

机译:小儿心脏手术后中性粒细胞明胶酶相关脂蛋白与小儿RIFLE全血评估对急性肾损伤的诊断和预后:横断面研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE:: To assess the ability of a single whole blood neutrophil gelatinase-associated lipocalin measurement in predicting acute kidney injury occurrence, its severity, and the need for postoperative renal replacement therapy after pediatric cardiac surgery. DESIGN:: Single-center prospective cross-sectional study. SETTING:: Tertiary care pediatric cardiac intensive care unit. PATIENTS:: Consecutive children <1 yr old with congenital heart diseases undergoing cardiac surgery with cardiopulmonary bypass. INTERVENTIONS:: None. MEASUREMENTS AND MAIN RESULTS:: Neutrophil gelatinase-associated lipocalin levels were measured after pediatric cardiac intensive care unit admission. Pediatric score indicating level of renal damage by Risk, Injury, Failure, Loss of function and End-stage kidney disease (pRIFLE) was used as the reference method. Acute kidney injury was diagnosed in 90 (56%) of the 160 enrolled patients. The number of abnormal neutrophil gelatinase-associated lipocalin samples (above the cutoff level of 150 ng/mL) was 12 over 90 (13%) in acute kidney injury population and 6 over 70 in non-acute kidney injury patients (8%) (odds ratio 1.6; 95% confidence interval 0.6-4.7; p = .31). Sensitivity of neutrophil gelatinase-associated lipocalin for acute kidney injury detection was 0.13 and specificity 0.91. The number of patients with abnormal neutrophil gelatinase-associated lipocalin samples was not significantly different within pediatric score indicating level of renal damage by pRIFLE (p = .69); furthermore, we found abnormal neutrophil gelatinase-associated lipocalin levels in 4 (30%) over 13 renal replacement therapy patients and in 14 (10%) over 133 children without renal replacement therapy need (odds ratio 4.2; 95% confidence interval 1.2-10.2; p = .02). Mean cross-clamp time (p = .28), inotropic score (p = .19), surgical risk score (p = .3), mean length of mechanical ventilation (p = .48), and pediatric cardiac intensive care unit stay (p = .57) did not significantly differ between children with abnormal and normal neutrophil gelatinase-associated lipocalin values. CONCLUSIONS:: Neutrophil gelatinase-associated lipocalin measured at pediatric cardiac intensive care unit arrival does not accurately predict acute kidney injury diagnosis, according to pediatric score indicating level of renal damage by pRIFLE classification. In these patients, neutrophil gelatinase-associated lipocalin might be helpful for renal replacement therapy prediction.
机译:目的:评估单次全血中性粒细胞明胶酶相关脂质运载蛋白测定在预测急性肾损伤发生,其严重性以及儿科心脏手术后需要进行肾脏替代治疗的能力。设计::单中心前瞻性横断面研究。地点:三级护理小儿心脏重症监护室。患者:<1岁的先天性心脏病连续儿童,接受体外循环心脏手术。干预措施::无。测量和主要结果:小儿心脏重症监护病房入院后测量中性粒细胞明胶酶相关的脂钙素水平。参照风险,伤害,衰竭,功能丧失和终末期肾脏疾病(pRIFLE)的小儿评分作为参考。在160名入组患者中,有90名(56%)被诊断为急性肾损伤。在急性肾损伤人群中,异常嗜中性白细胞明胶酶相关的脂钙蛋白样本的数量(超过150 ng / mL的临界水平)在90(13%)以上为12,在非急性肾损伤患者中为70(6)在70以上(8%)(比值比为1.6; 95%置信区间为0.6-4.7; p = 0.31)。中性粒细胞明胶酶相关脂质运载蛋白对急性肾损伤检测的敏感性为0.13,特异性为0.91。在儿科评分内,中性粒细胞明胶酶相关脂钙蛋白样本异常的患者人数无显着差异,表明pRIFLE对肾脏的损害水平(p = .69);此外,我们发现13名需要肾脏替代治疗的儿童中有4名(30%)和133名不需要肾脏替代治疗的儿童中有中性粒细胞明胶酶相关的脂蛋白水平异常(优势比4.2; 95%置信区间1.2-10.2) ; p = .02)。平均交叉钳位时间(p = .28),肌力评分(p = .19),手术风险评分(p = .3),平均机械通气时间(p = .48)和小儿心脏重症监护病房住院时间(p = .57)在嗜中性粒细胞明胶酶相关脂钙蛋白值异常和正常的儿童之间没有显着差异。结论:根据pRIFLE分类显示的肾脏损害程度,儿科评分显示,在儿科心脏重症监护病房到来时测量的中性粒细胞明胶酶相关脂质运载蛋白不能准确预测急性肾损伤的诊断。在这些患者中,中性粒细胞明胶酶相关的脂钙蛋白可能有助于预测肾脏替代治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号